Kathleen Sebelius - 13 Jun 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Kathleen Sebelius by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
13 Jun 2024
Net transactions value
+$100,836
Form type
4
Filing time
17 Jun 2024, 16:15:53 UTC
Previous filing
16 Jun 2023
Next filing
11 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Options Exercise $100,836 +39,389 $2.56 39,389 14 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +50,000 $0.000000 50,000 13 Jun 2024 Common Stock 50,000 $7.20 Direct F1
transaction HUMA Stock Options (right to buy) Options Exercise $0 -39,389 -100% $0.000000* 0 14 Jun 2024 Common Stock 39,389 $2.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028.